Cargando…

Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic

PURPOSE: Identification of demographic, physical/physiological, lifestyle and genetic factors contributing to the onset of dementia, specifically Alzheimer disease (AD), and implementation of novel methods for early diagnosis are important to alleviate prevalence of dementia globally. The Czech Brai...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheardova, Katerina, Vyhnalek, Martin, Nedelska, Zuzana, Laczo, Jan, Andel, Ross, Marciniak, Rafal, Cerman, Jiri, Lerch, Ondrej, Hort, Jakub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937049/
https://www.ncbi.nlm.nih.gov/pubmed/31857299
http://dx.doi.org/10.1136/bmjopen-2019-030379
_version_ 1783483812090478592
author Sheardova, Katerina
Vyhnalek, Martin
Nedelska, Zuzana
Laczo, Jan
Andel, Ross
Marciniak, Rafal
Cerman, Jiri
Lerch, Ondrej
Hort, Jakub
author_facet Sheardova, Katerina
Vyhnalek, Martin
Nedelska, Zuzana
Laczo, Jan
Andel, Ross
Marciniak, Rafal
Cerman, Jiri
Lerch, Ondrej
Hort, Jakub
author_sort Sheardova, Katerina
collection PubMed
description PURPOSE: Identification of demographic, physical/physiological, lifestyle and genetic factors contributing to the onset of dementia, specifically Alzheimer disease (AD), and implementation of novel methods for early diagnosis are important to alleviate prevalence of dementia globally. The Czech Brain Aging Study (CBAS) is the first large, prospective study to address these issues in Central/Eastern Europe by enrolling non-demented adults aged 55+ years, collecting a variety of personal and biological measures and tracking cognitive function over time. PARTICIPANTS: The CBAS recruitment was initiated in 2011 from memory clinics at Brno and Prague University Hospitals, and by the end of 2018, the study included 1228 participants. Annual follow-ups include collection of socioeconomic, lifestyle and personal history information, neurology, neuropsychology, laboratory, vital sign and brain MRI data. In a subset, biomarker assessment (cerebrospinal fluid (CSF) and amyloid positron emission tomography) and spatial navigation were performed. Participants were 69.7±8.1 years old and had 14.6±3.3 years of education at baseline, and 59% were women. By the end of 2018, 31% finished three and more years of follow-up; 9% converted to dementia. Apolipoprotein E status is available from 95% of the participants. The biological sample bank linked to CBAS database contained CSF, serum and DNA. FINDINGS TO DATE: Overall, the findings, mainly from cross-sectional analyses, indicate that spatial navigation is a promising marker of early AD and that it can be distinguished from other cognitive functions. Specificity of several standard memory tests for early AD pathology was assessed with implications for clinical practice. The relationship of various lifestyle factors to cognition and brain atrophy was reported. FUTURE PLANS: Recruitment is ongoing with secured funding. Longitudinal data analyses are currently being conducted. Proposals for collaboration on specific data from the database or biospecimen, as well as collaborations with similar cohort studies to increase sample size, are welcome. Study details are available online (www.cbas.cz).
format Online
Article
Text
id pubmed-6937049
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-69370492020-01-06 Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic Sheardova, Katerina Vyhnalek, Martin Nedelska, Zuzana Laczo, Jan Andel, Ross Marciniak, Rafal Cerman, Jiri Lerch, Ondrej Hort, Jakub BMJ Open Epidemiology PURPOSE: Identification of demographic, physical/physiological, lifestyle and genetic factors contributing to the onset of dementia, specifically Alzheimer disease (AD), and implementation of novel methods for early diagnosis are important to alleviate prevalence of dementia globally. The Czech Brain Aging Study (CBAS) is the first large, prospective study to address these issues in Central/Eastern Europe by enrolling non-demented adults aged 55+ years, collecting a variety of personal and biological measures and tracking cognitive function over time. PARTICIPANTS: The CBAS recruitment was initiated in 2011 from memory clinics at Brno and Prague University Hospitals, and by the end of 2018, the study included 1228 participants. Annual follow-ups include collection of socioeconomic, lifestyle and personal history information, neurology, neuropsychology, laboratory, vital sign and brain MRI data. In a subset, biomarker assessment (cerebrospinal fluid (CSF) and amyloid positron emission tomography) and spatial navigation were performed. Participants were 69.7±8.1 years old and had 14.6±3.3 years of education at baseline, and 59% were women. By the end of 2018, 31% finished three and more years of follow-up; 9% converted to dementia. Apolipoprotein E status is available from 95% of the participants. The biological sample bank linked to CBAS database contained CSF, serum and DNA. FINDINGS TO DATE: Overall, the findings, mainly from cross-sectional analyses, indicate that spatial navigation is a promising marker of early AD and that it can be distinguished from other cognitive functions. Specificity of several standard memory tests for early AD pathology was assessed with implications for clinical practice. The relationship of various lifestyle factors to cognition and brain atrophy was reported. FUTURE PLANS: Recruitment is ongoing with secured funding. Longitudinal data analyses are currently being conducted. Proposals for collaboration on specific data from the database or biospecimen, as well as collaborations with similar cohort studies to increase sample size, are welcome. Study details are available online (www.cbas.cz). BMJ Publishing Group 2019-12-18 /pmc/articles/PMC6937049/ /pubmed/31857299 http://dx.doi.org/10.1136/bmjopen-2019-030379 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology
Sheardova, Katerina
Vyhnalek, Martin
Nedelska, Zuzana
Laczo, Jan
Andel, Ross
Marciniak, Rafal
Cerman, Jiri
Lerch, Ondrej
Hort, Jakub
Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic
title Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic
title_full Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic
title_fullStr Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic
title_full_unstemmed Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic
title_short Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic
title_sort czech brain aging study (cbas): prospective multicentre cohort study on risk and protective factors for dementia in the czech republic
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937049/
https://www.ncbi.nlm.nih.gov/pubmed/31857299
http://dx.doi.org/10.1136/bmjopen-2019-030379
work_keys_str_mv AT sheardovakaterina czechbrainagingstudycbasprospectivemulticentrecohortstudyonriskandprotectivefactorsfordementiaintheczechrepublic
AT vyhnalekmartin czechbrainagingstudycbasprospectivemulticentrecohortstudyonriskandprotectivefactorsfordementiaintheczechrepublic
AT nedelskazuzana czechbrainagingstudycbasprospectivemulticentrecohortstudyonriskandprotectivefactorsfordementiaintheczechrepublic
AT laczojan czechbrainagingstudycbasprospectivemulticentrecohortstudyonriskandprotectivefactorsfordementiaintheczechrepublic
AT andelross czechbrainagingstudycbasprospectivemulticentrecohortstudyonriskandprotectivefactorsfordementiaintheczechrepublic
AT marciniakrafal czechbrainagingstudycbasprospectivemulticentrecohortstudyonriskandprotectivefactorsfordementiaintheczechrepublic
AT cermanjiri czechbrainagingstudycbasprospectivemulticentrecohortstudyonriskandprotectivefactorsfordementiaintheczechrepublic
AT lerchondrej czechbrainagingstudycbasprospectivemulticentrecohortstudyonriskandprotectivefactorsfordementiaintheczechrepublic
AT hortjakub czechbrainagingstudycbasprospectivemulticentrecohortstudyonriskandprotectivefactorsfordementiaintheczechrepublic